How Does Any Pandemic or Epidemic Accelerate Medical Gloves Usage?

 As per the estimates of the World Health Organization (WHO) non-communicable diseases (NCDs) or chronic diseases account for nearly 71% of the global deaths. The WHO states that approximately 1.5 million, 4.1 million, 9.3 million, and 17.9 million deaths across the world are caused by diabetes, respiratory diseases, cancer, and cardiovascular diseases (CVDs), respectively, every year. The surging prevalence of such chronic diseases is leading to a significant surge in the number of surgeries, which, in turn, is expected to generate a huge requirement for medical gloves in the coming years.

Get Detailed COVID-19 Impact Analysis on the Medical Gloves Market

Moreover, the ongoing COVID-19 pandemic will also help the medical gloves market progress at a healthy CAGR of 10.8% during 2020–2030. The market was valued at $6,633.4 million in 2019 and it is projected to generate $20,435.6 million revenue by 2030. Currently, medical professions are using protective medical items, such as surgical and examination gloves, to contain the spread of coronavirus, as it is transmitted through direct contact. Additionally, the recent outbreak of severe acute respiratory syndrome (SARS), Ebola, Zika, and Middle East respiratory syndrome (MERS) has also augmented the usage of medical gloves worldwide.

In contemporary times, medical professionals are preferring nitrile gloves over latex, vinyl, and neoprene ones, due to their non-allergic properties. Additionally, nitrile gloves exhibit high puncture resistance and they are considered ideal for surgical and medical examination applications. Hospitals, clinics and diagnostic centers and ambulatory surgery centers (ASCs) use a wide variety of sterile and non-sterile medical gloves produced by Kimberly-Clark Corporation, Riverstone Holdings Limited, B. Braun Melsungen AG, Dynarex Corporation, Paul Hartmann AG, SHIELD Scientific B.V., and Medline Industries Inc.

According to P&S Intelligence, North America will dominate the medical gloves market in the foreseeable future, due to the surging prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, in the region. For instance, the Centers for Disease Control and Prevention (CDC) estimates that 25,131,132 people were suffering from asthma in the U.S. in 2019. Besides, the outbreak of the COVID-19 pandemic and the presence of a large number of medical glove producing companies are also propelling the sales of these products in the region. 

Furthermore, the Asia-Pacific (APAC) region is expected to create an extensive requirement for medical gloves in the forthcoming years, due to the booming geriatric population, soaring cases of COVID-19, and increasing volume of surgical procedures and diagnostic examinations. The United Nations Population Fund (UNFPA) forecasts that the number of people aged more than 60 years in APAC will reach around 1.3 billion by 2050. Additionally, the improving healthcare infrastructure will also contribute toward the booming demand for medical gloves in the region. 

Therefore, the ongoing COVID-19 pandemic and rising incidence of chronic illnesses will propel the usage of medical gloves in the forthcoming years.  

Read More

Increasing Stem Cell Transplant Procedures Pushing Up Medical Gloves Sales in Asia-Pacific

With the recent outbreaks of various contagious diseases such as Middle East respiratory syndrome (MERS), Zika, severe acute respiratory syndrome (SARS), and Ebola, medical gloves are increasingly becoming extremely essential in healthcare operations. The outbreak of the COVID-19 (SARS CoV-2) pandemic has further pushed up the requirement for medical gloves, on account of their ability to prevent direct contact between persons, which is very essential for reducing the spread of the coronavirus.

To learn more about this report: https://bit.ly/3iR7rGf

As per the estimates of the World Health Organization (WHO), the incidence of chronic diseases would rise by as much as 57% by the end of 2020. Due to soaring population, the prevalence of chronic diseases would grow massively in the developing nations in the coming years. Furthermore, the increasing prevalence of these diseases is pushing up the requirement for surgeries. For example, as per reports, in Mexico, 4,900 coronary artery bypass graft surgeries were performed in 2015.

This number rose to 5,125 in 2016 in the country. Similarly, in France, the number of such surgeries grew from 19,242 to 19,310 from 2015 to 2016. Because of these reasons, the sales of medical gloves are skyrocketing across the world. This is causing the expansion of the global medical gloves market. As a result, the value of the global medical gloves market is predicted to grow from $6,633.4 million to $20,435.6 million from 2019 to 2030.

Geographically, the medical gloves market is predicted to demonstrate the fastest advancement in the Asia-Pacific (APAC) region in the upcoming years, due to the increasing geriatric population, surging number of diagnostic examinations and surgical procedures, and the soaring cases of COVID-19 in the regional countries. In addition to this, the increasing number of stem cell transplant procedures in the APAC countries is fueling the demand for medical gloves in the region.

Therefore, it can be said without any doubt that the sales of medical gloves are predicted to rise enormously all over the world in the coming years, primarily because of the growing incidence of contagious and chronic diseases, the recent outbreak of the COVID-19 pandemic, and the rising awareness about hygiene among the people and healthcare practitioners.

Read more: https://www.psmarketresearch.com/market-analysis/medical-gloves-market-report

Read More